Our Services
Medical Information
Helpful Resources
Published on: 9/17/2026
Ashwagandha is usually well tolerated, but reports and its known effects on thyroid hormone, blood pressure, sedation, and heart rate suggest it can occasionally trigger palpitations, an irregular heartbeat, or worsening cardiac symptoms in seniors, particularly those with existing heart disease, atrial fibrillation, or who take thyroid, blood pressure, sedative, or blood-thinning medications. Whether the supplement is truly to blame depends on dosage, duration, interactions, and underlying conditions, and those important details are explained below. Warning signs such as a racing or fluttering pulse, chest pressure, breathlessness, dizziness, or fainting call for prompt medical evaluation rather than waiting it out. Because irregular heartbeats in older adults also arise from electrolyte imbalances, thyroid disease, anemia, dehydration, and other medications, it helps to narrow down the likely cause before stopping or continuing any supplement. A free, instant, online symptom check takes only a few minutes,
Can Ashwagandha Cause an Irregular Heartbeat or Heart Attack in Seniors?
Optimizing for: Ashwagandha and heart medication safety
Ashwagandha (Withania somnifera) is a popular herb in traditional Ayurvedic medicine. Seniors are increasingly turning to it for stress relief, improved sleep, and better overall well-being. But if you’re over 65—or caring for someone who is—it’s natural to ask: “Could ashwagandha trigger an irregular heartbeat or even a heart attack?” Here’s what current, credible research tells us, and how you can keep “Ashwagandha and heart medication safety” front and center in your health plan.
These effects can benefit many—but in seniors, even small shifts in blood pressure or heart rate deserve careful attention.
• Blood Pressure: Several studies report modest reductions in both systolic and diastolic pressures, typically 5–10 mmHg.
• Heart Rate: A small number of trials note slight decreases in resting heart rate—again, usually under 5–10 beats per minute.
• Thyroid Activity: Ashwagandha may raise thyroid hormone levels in some people, increasing metabolic rate and potentially heart workload.
None of these studies—mostly in younger adults—documented serious arrhythmias or heart attacks directly linked to ashwagandha. But seniors often have less cardiovascular reserve and take medications that influence heart function, so even modest changes matter more.
• Stiffer arteries make blood pressure less flexible.
• Reduced kidney function slows elimination of drugs and supplements.
• Multiple medications (polypharmacy) increase interaction risk.
• Pre-existing arrhythmias or conduction issues are more common.
Because seniors often take heart medications—such as beta-blockers, calcium channel blockers, ACE inhibitors, or anti-arrhythmics—it’s vital to consider “Ashwagandha and heart medication safety” before adding any new supplement.
• Beta-blockers (e.g., metoprolol, propranolol): Combined use may lead to an overly slow heart rate (bradycardia).
• Calcium channel blockers (e.g., amlodipine): Risk of excessive blood pressure drop and lightheadedness.
• Anti-arrhythmics (e.g., amiodarone): Unpredictable changes in heart conduction could worsen arrhythmias.
• Thyroid hormones or anti-thyroid drugs: Ashwagandha’s impact on thyroid levels can destabilize heart rhythms.
Always discuss any new supplement with your prescribing physician or cardiologist to adjust doses safely.
• Animal studies hint at changes in cardiac cell function at very high doses.
• A few individuals report palpitations after starting ashwagandha—especially those on heart medications or with underlying thyroid issues.
• Rapid changes in blood pressure (even modest) can unmask a tendency toward irregular rhythms in vulnerable seniors.
In practice, irregular heartbeats linked to ashwagandha appear rare. But the anecdotal signals and known drug interactions mean caution is warranted.
• Hypotension leading to reduced coronary perfusion (blood flow to the heart).
• Thyroid overstimulation increasing heart workload without adequate oxygen supply.
• Unrecognized arrhythmias progressing to more dangerous rhythms.
Again, these are theoretical risks based on how the herb affects physiology. No clinical trial has directly linked ashwagandha to myocardial infarction.
Best Practices for “Ashwagandha and Heart Medication Safety”
If you’re a senior considering ashwagandha, or you’re a caregiver, follow these guidelines:
Review Medications First
– List all prescriptions, over-the-counter drugs, and supplements.
– Discuss potential interactions with your doctor or pharmacist.
Start Low and Go Slow
– Begin with a low dose (e.g., 125–250 mg standardized extract).
– Monitor blood pressure and heart rate daily for the first 2–4 weeks.
Keep a Symptom Log
– Note any palpitations, dizziness, chest discomfort, or unusual fatigue.
– Record readings from your home blood pressure cuff.
Perform a Free, Online Symptom Check
– If you notice new or concerning symptoms, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Schedule Regular Check-Ins
– Share your logs and any Ubie report with your healthcare provider.
– Adjust medication dosages as needed, under professional supervision.
When to Hold or Stop Ashwagandha
Pause use and seek medical advice if you experience:
• Persistent palpitations or skipped beats
• New-onset dizziness or fainting
• Chest pain or pressure
• Sudden, unexplained fatigue
These symptoms could signal serious heart rhythm disturbances or other cardiac issues that need prompt evaluation.
Balancing Benefits and Risks
Many seniors find ashwagandha improves sleep, reduces stress, and even supports joint comfort. But the heart is not a system to experiment on casually—especially if you already take cardiovascular medications. By proactively managing “Ashwagandha and heart medication safety,” you maximize potential benefits while minimizing risks.
Final Takeaway & Next Steps
If you ever feel something serious—like chest pain, severe palpitations, or fainting—call emergency services immediately. Otherwise, bring your questions, logs, and any Ubie report to your next medical appointment. Being proactive and communicative ensures you get the most out of ashwagandha without compromising heart health.
Speak to a doctor about any life-threatening or serious concerns you may have.
(References)
* Mohanty I, Arya DS, Dinda A, Talwar KK, Joshi S, Gupta SK. Mechanisms of cardioprotective effect of Withania somnifera in experimentally induced myocardial infarction. Basic Clin Pharmacol Toxicol. 2004 Apr;94(4):184-90. doi: 10.1111/j.1742-7843.2004.pto940405.x. PMID: 15078343.
* Gupta SK, Mohanty I, Talwar KK, Dinda A, Joshi S, Bansal P, Saxena A, Arya DS. Cardioprotection from ischemia and reperfusion injury by Withania somnifera: a hemodynamic, biochemical and histopathological assessment. Mol Cell Biochem. 2004 May;260(1-2):39-47. doi: 10.1023/b:mcbi.0000026051.16803.03. PMID: 15228084.
* Thirunavukkarasu M, Penumathsa S, Juhasz B, Zhan L, Bagchi M, Yasmin T, Shara MA, Thatte HS, Bagchi D, Maulik N. Enhanced cardiovascular function and energy level by a novel chromium (III)-supplement. Biofactors. 2006;27(1-4):53-67. doi: 10.1002/biof.5520270106. PMID: 17012764.
* Khalil MI, Ahmmed I, Ahmed R, Tanvir EM, Afroz R, Paul S, Gan SH, Alam N. Amelioration of Isoproterenol-Induced Oxidative Damage in Rat Myocardium by Withania somnifera Leaf Extract. Biomed Res Int. 2015;2015:624159. doi: 10.1155/2015/624159. Epub 2015 Oct 11. PMID: 26539517; PMCID: PMC4619872.
* Brown AC. Heart Toxicity Related to Herbs and Dietary Supplements: Online Table of Case Reports. Part 4 of 5. J Diet Suppl. 2018 Jul 4;15(4):516-555. doi: 10.1080/19390211.2017.1356418. Epub 2017 Oct 5. PMID: 28981338.
* Allawadhi P, Khurana A, Sayed N, Kumari P, Godugu C. Isoproterenol-induced cardiac ischemia and fibrosis: Plant-based approaches for intervention. Phytother Res. 2018 Oct;32(10):1908-1932. doi: 10.1002/ptr.6152. Epub 2018 Jul 15. PMID: 30009418.
* Guo R, Gan L, Lau WB, Yan Z, Xie D, Gao E, Christopher TA, Lopez BL, Ma X, Wang Y. Withaferin A Prevents Myocardial Ischemia/Reperfusion Injury by Upregulating AMP-Activated Protein Kinase-Dependent B-Cell Lymphoma2 Signaling. Circ J. 2019 Jul 25;83(8):1726-1736. doi: 10.1253/circj.CJ-18-1391. Epub 2019 Jun 20. PMID: 31217391.
* Yadav B, Rai A, Mundada PS, Singhal R, Rao BCS, Rana R, Srikanth N. Safety and efficacy of Ayurvedic interventions and Yoga on long term effects of COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials. 2021 Jun 3;22(1):378. doi: 10.1186/s13063-021-05326-1. Epub 2021 Jun 3. PMID: 34082792; PMCID: PMC8173507.
* Patil VS, Hupparage VB, Malgi AP, Deshpande SH, Patil SA, Mallapur SP. Dual inhibition of COVID-19 spike glycoprotein and main protease 3CLpro by Withanone from Withania somnifera. Chin Herb Med. 2021 Jul;13(3):359-369. doi: 10.1016/j.chmed.2021.06.002. Epub 2021 Jun 24. PMID: 34188665; PMCID: PMC8222985.
* Siwek M, Woroń J, Wrzosek A, Gupało J, Chrobak AA. Harder, better, faster, stronger? Retrospective chart review of adverse events of interactions between adaptogens and antidepressant drugs. Front Pharmacol. 2023;14:1271776. doi: 10.3389/fphar.2023.1271776. Epub 2023 Sep 27. PMID: 37829299; PMCID: PMC10565488.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.